The Importance of Colonoscopy in Inflammatory Bowel Diseases

Abstract

Introduction: Endoscopic evaluation, particularly the macroscopic mucosal and histological results of ileocolic biopsies, is essential for the management of inflammatory bowel disease. Endoscopic appearance is not always sufficient to differentiate Crohn’s disease and ulcerative colitis, but there are some characteristics that favor one or another diagnosis. Both diseases have an increased incidence of colorectal carcinoma; so, surveillance colonoscopy is important for detecting early neoplastic lesions. Objective: To update the importance of endoscopy in the evaluation, diagnosis and prognosis of inflammatory bowel disease. Method: Search was done in the scientific literature of the TRIP database, chosen from clinical questions (PICO) with the following descriptors: “inflammatory bowel disease”, “endoscopy/colonoscopy”, “Crohn’s disease”, “ulcerative colitis” and “diagnosis/treatment”. Results: Endoscopic investigation in patients with chronic colitis is quite accurate for the differential diagnosis between ulcerative colitis and Crohn’s disease. Endoscopy is indicated for ulcerative colitis during severe crisis due to its prognostic value. Another accepted indication for endoscopy in inflammatory bowel disease is its use in the screening for dysplastic lesion. Conclusion: Ileocolonoscopy allows an accurate diagnosis of Crohn’s disease or ulcerative colitis in up to 90% of cases. The healing of the mucosa assessed by endoscopy after treatments despite not being consensus is still the gold-standard in the evaluation of remission of the disease. Colonoscopy is essential for long-term cancer surveillance and in the future the implementation of Confocal Laser Endomicroscopy seems to be very promising in assessing the initial dysplasia.

Is Superficial Colorectal Lesions With Low and High Grades Intraepithelial Neoplasms More Prevalent in Older Above 65 Years?

“…Colorectal malignant neoplasia is considered the third leading cause of cancer in the world and the second in death rate from cancer in North America and Western Europe 15 . In Brazil, the incidence varies according to the geographic region, being higher in the South and Southeast and lower in the Midwest, Northeast and North 5 , 6 .…”

Predictive Factors for Loss of Response to Anti-TNF in Crohn’s Disease

“…For the appropriate choice of the best therapeutic approach, it is necessary to consider a number of factors, including the degree of clinical and endoscopic activity of the disease, location, extent, behavior, efficacy of the drug and its potential side effects, prior response to some type of treatment, presence of extraintestinal manifestations or disease-related complications, in addition to the cost-effectiveness issue 4 , 13 . In addition, there are available methods to evaluate possible causes of loss of anti-TNF response, but they are high cost, with little availability, making them unviable 17 , especially in our country.…”

Serum expression of microRNA-16 in a cohort of Egyptian patients with ulcerative colitis and its correlation with disease extent and severity

“…13,14 Colonoscopy is the gold standard for making the diagnosis of UC by allowing direct visualization of the colon and taking multiple tissue biopsies for histopathologic analysis to confirm the diagnosis. 15 Radiological modalities used for diagnosis and assessment of UC include Computerized Tomography Enterography (CTE) and Magnetic Resonance Enterography (MRE). 16 MicroRNAs (miRNA or miR) are small (about 18-22 nucleotides in length), highly conserved, single stranded, noncoding RNA molecules that bind target miR to prevent protein production.…”